LifeSiteNews has been permanently banned on YouTube. Click HERE to sign up to receive emails when we add to our video library.
July 13, 2021 (LifeSiteNews) – The Food and Drug Administration (FDA) announced on Monday that it has added a label to Johnson & Johnson’s COVID-19 vaccine that warns of a risk of Guillain-Barré syndrome (GBS), a rare neurological disorder that can cause paralysis.
The new warning comes in response to 100 preliminary reports of GBS after vaccination with the shot that have been tracked by the Vaccine Adverse Event Reporting System (VAERS), the Epoch Times said. VAERS, a vaccine injury tracking system managed by the FDA and the Centers for Disease Control and Prevention (CDC) is known to underreport cases.
Of the Guillain-Barré reports submitted to VAERS, 95 were serious and required hospitalization, an FDA spokesperson told the Epoch Times. One death has been recorded so far: that of a 57-year-old Delaware man who had had a heart attack and a stroke in the past four years.
A CDC communications official told Fox News that GBS cases “have largely been reported about two weeks after vaccination and mostly in males, many aged 50 years and older.” Those
vaccinated with
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
